info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
United States Flag  US: +1-315-636-4233    United Kingdom Flag  UK: +44-162-237-0614    Indian Flag  IN: +91-826-083-6500
smrlogonew
  • Home
  • About
    • Why SMR
    • Research Methodology
    • Media Coverage
    • Join Our Team
  • Reports
    • Aerospace and Defense
    • Agriculture
    • Automotive
    • Chemicals and Materials
    • Consumer Goods
    • Energy and Power
    • Equipment and Machinery
    • Food and Beverages
    • Healthcare
    • Information and Communication Technology
    • Semiconductor and Electronics
    • Manufacturing and Construction
  • Our Practices
    • Syndicated Research
    • Consulting Services
    • Custom Research
    • Full-time Engagement Model
  • Insights
    • Press Release
    • Blog
  • Contact
Home » Press Releases » Single-Cell Analysis Market worth $ 6.45 billion by 2028

Single-Cell Analysis Market worth $ 6.45 billion by 2028


Published Date: Mar-2022 | Report Format:Electronic (PDF)

 

The report ‘Single-cell analysis’ Market by Product (Consumables, Instruments), by Application (Research Applications, Medical Applications), - Global Forecast to 2028. The Market for Global Single Cell Analysis is estimated to reach a market value of USD 6.45 billion by 2028 from USD $ 2.42 billion in 2020, at a CAGR of 15.6% during the forecasted period. The single-cell analysis industry is expected to grow in the coming years due to factors such as technological advancements in single-cell analysis products, growing focus on personalized medicine, increased R&D in the single-cell analysis field, quick progress in the healthcare segment throughout the world, and partnerships among the key players to favour the development of the market.

To know more about the report, Click on the link https://www.strategicmarketresearch.com/market-report/single-cell-analysis-market

 

Consumables, which accounted for 67.4 percent of total market revenue in 2020, dominated the single-cell analysis market. 

This segment's large proportion could be attributed to the fact that these products are used on a regular basis, as opposed to instruments, which are considered as a one-time investment. The numerous applications of consumables in research and genetic exploration, exosome analysis, and RNA and DNA separation are also expected to drive market growth. Also, because of their high-end features and technically complex analytical options, automated instruments contributed to the market's considerable revenue.

 

The Research Applications category is predicted to increase at a respectable rate over the projected timeframe. 

The ‘research applications’ market segment is expected to hold the largest single cell analysis market share due to the increasing rates of cancer cases and the growing need for stem cell research, and the increased awareness of commercially available cancer diagnostics and precision medicine. Cancer and immunology are two fields of study that are becoming increasingly popular among scientists.

 

North America, with 44.9 percent of the global single-cell analysis market in 2020, had the largest share of the market. 

Increased personal healthcare spending, high government funding, quick adoption of novel analytical techniques, and increased awareness all had a big role in the contribution of the growth of the market in North America. In recent years, factors such as the booming medical tourism industry, rising disposable income, and rapidly developing healthcare infrastructure have boosted demand for advanced diagnostic tools in Asia Pacific's emerging nations. The market in this area is expected to be driven by concentrated efforts, with the highest CAGR during the forecasted period. Furthermore, the rising occurrences of chronic diseases such as cancer in the region are driving the market growth. According to the Globocan 2020 estimate, 2,281,658 new cancer cases will be identified in the United States in 2020, with over 612,390 deaths. In 2020, the most common cancers in the United States were breast (253,465), prostate (209,512), lung (227,875), and colon (101,809).

 

Key market players in the market are Thermo Fisher Scientific Inc., QIAGEN NV, Bio-Rad Laboratories Inc., Illumina Inc., Merck Millipore, Becton, Dickinson & Company, Fluidigm Corporation, 10x Genomics, Inc., BGI, Novogene Corporation

 

Recent Developments

  • in March 2021, Beckman Coulter announced the CytoFLEX SRT Benchtop Sorter that has improved laser and colour options for use in labs of various sizes.
  • In March 2020, Fluidigm Corporation (US) and the Singapore Immunology Network (SIgN) opened a new Imaging Mass Cytometry (IMC) Center of Excellence (CoE) in Singapore.
  • In April 2020, Mission Bio Inc. and Agilent Technologies Inc. made a co-marketing agreement to help Mission Bio's Tapestri Platform, a multi-omic device that analyses DNA and protein at the single-cell level.
  • In April 2020, Bio-Rad Laboratories, Inc. completed the acquisition of Celsee, Inc., broadening its precision medicine and single-cell analysis product portfolio.

 

Choose License Type



$0
$0
$0
Buy Now
"Click to avail the latest sample copy of the report"
Request Sample
"Probe before placing the order"
Pre-Order Enquiry
"Let's optimize your ROI by furnishing the best price"
Request Discount
"Want to curate the report according to your business needs:"
Ask for Customization

Trust Online

  • paypal.png
  • wiretransfers

Follow Us

  • facebook
  • twitter
  • instagram
  • linkedin

Contact Us

  • US: (+1) 315-636-4233
  • UK: (+44) 1622-370-614
  • IN: (+91) 826-083-6500
  • info@strategicmarketresearch.com
  • Strategic Market Research
    26, Broadway Suite 934, New York , 10004

Quick Link

  • Why SMR
  • Research Methodology
  • Media Coverage
  • Join Our Team
  • Press Release
  • Blog

Customer Support

  • FAQs
  • Contact
  • Terms of Use
  • Privacy Policy
  • Disclaimer Policy
  • Return Policy
Copyright © 2022 Strategic Market Research All rights reserved